Sullivan and colleagues took a broader approach, performing a shRNA knockdown screen of more than 50 AD candidate genes in iPSC-derived neurons, examining effects on Aβ secretion and tau phosphorylation [116]. The gene discussed is MAPT; the disease is Alzheimer disease.